EUVIMEDEUVIMED entdecken
Crossref

Histopathologic Differential Diagnosis and Estrogen Receptor/Progesterone Receptor Immunohistochemical Evaluation of Breast Carcinoma Using a Deep Learning–Based Artificial Intelligence Architecture

Zhi Han, Shihong Ding, Baichen Liu, Yandong Tang, Xueshan Qiu, Enhua Wang, Huanyu Zhao

The American Journal of Pathology · 2024

DOI: 10.1016/j.ajpath.2024.08.011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Journal of Pathology, 2024. Verfasst von Zhi Han und 6 weiteren Autor:innen. Beteiligte Einrichtung: The State Key Laboratory of Robotics, Shenyang Institute of Automation, Chinese Academy of Sciences, Shenyang, China; Institute for Robotics and Inte…. Hauptthemen laut MEDLINE: Deep Learning, Breast Neoplasms, Receptors, Progesterone, Receptors, Estrogen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Key Research and Development Program of China Stem Cell and Translational Research, Department of Science and Technology of Liaoning Province, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In breast carcinoma, invasive ductal carcinoma (IDC) is the most common histopathologic subtype, and ductal carcinoma in situ (DCIS) is a precursor of IDC. These two often occur concomitantly. The immunohistochemical staining of estrogen receptor (ER)/progesterone receptor (PR) in IDC/DCIS on histopathologic whole slide images (WSIs) can predict the prognosis of patients. Artificial intelligence (AI) technology has the potential to substantially reduce the interobserver variability among pathologists reading WSIs. Herein, IDC/DCIS detection was conducted by a deep learning approach, including faster region-based convolutional neural network (Faster R-CNN), RetinaNet, single-shot multibox detector 300 (SSD300), you only look once (YOLO) v3, YOLOv5, YOLOv7, YOLOv8, and Swin transformer. Their performance was estimated by mean average precision (mAP) values. Cell recognition and counting were performed using AI technology to evaluate the intensity and proportion of ER/PR-immunostained cancer cells in IDC/DCIS. A three-round ring study (RS) was conducted to assess WSIs. A database for modelling the underlying probability distribution of a data set with labels was established. YOLOv8 exhibited the highest detection performance with an mAP at 0.5 of 0.944 and an mAP at 0.5 to 0.95 of 0.790. With the assistance of YOLOv8, the scoring concordance across all pathologists was boosted to excellent in RS3 (0.970) from moderate in RS1 (0.724) and good in RS2 (0.812). Deep learning detection can be applied in the clinicopathologic field. Herein, a novel AI architecture and well-organized data set were developed to facilitate the histopathologic diagnosis of IDC/DCIS and immunostaining scoring of ER/PR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Deep LearningBreast NeoplasmsReceptors, ProgesteroneReceptors, EstrogenImmunohistochemistryArtificial IntelligenceCarcinoma, Ductal, BreastHumansFemaleDiagnosis, DifferentialBiomarkers, TumorCarcinoma, Intraductal, Noninfiltrating

Substanzen

Receptors, ProgesteroneReceptors, EstrogenBiomarkers, Tumor

Autor:innen und Institutionen

  • The State Key Laboratory of Robotics, Shenyang Institute of Automation, Chinese Academy of Sciences, Shenyang, China; Institute for Robotics and Intelligent Manufacturing, Chinese Academy of Sciences, Shenyang, China.
  • Shenyang Ligong University, Shenyang, China.
  • Department of Pathology, The First Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, China.
  • Department of Pathology, The First Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, China. Electronic address: wangeh55@outlook.com.
  • Department of Pathology, The First Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, China. Electronic address: zhaohy@cmu.edu.cn.

Förderung

  • National Key Research and Development Program of China Stem Cell and Translational Research
  • Department of Science and Technology of Liaoning Province
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Natural Science Foundation of Liaoning Province
  • Chinese Academy of Sciences Youth Innovation Promotion Association

Zitieren

APA

Han, Z., Ding, S., Liu, B., Tang, Y., Qiu, X., Wang, E., & Zhao, H. (2024). Histopathologic Differential Diagnosis and Estrogen Receptor/Progesterone Receptor Immunohistochemical Evaluation of Breast Carcinoma Using a Deep Learning–Based Artificial Intelligence Architecture. The American Journal of Pathology. https://doi.org/10.1016/j.ajpath.2024.08.011

Vancouver

Han Z, Ding S, Liu B, Tang Y, Qiu X, Wang E, et al. Histopathologic Differential Diagnosis and Estrogen Receptor/Progesterone Receptor Immunohistochemical Evaluation of Breast Carcinoma Using a Deep Learning–Based Artificial Intelligence Architecture. The American Journal of Pathology. 2024. doi:10.1016/j.ajpath.2024.08.011

BibTeX
@article{Han2024,
  author = {Han, Zhi and Ding, Shihong and Liu, Baichen and Tang, Yandong and Qiu, Xueshan and Wang, Enhua and Zhao, Huanyu},
  title = {Histopathologic Differential Diagnosis and Estrogen Receptor/Progesterone Receptor Immunohistochemical Evaluation of Breast Carcinoma Using a Deep Learning–Based Artificial Intelligence Architecture},
  journal = {The American Journal of Pathology},
  year = {2024},
  doi = {10.1016/j.ajpath.2024.08.011}
}
Kostenlos starten →